Top pick: US: Woman dies after she was set on fire in New York subway, suspect arrested

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Just Earth News | @justearthnews | 21 May 2021

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Wikimedia Commons

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

PHE estimates that 13,000 deaths have now been prevented in people aged 60 years or older in England up to 9 May 2021 (11,100 deaths in individuals aged 80 years and older, 1,600 in individuals aged 70 to 79 and 300 in individuals aged 60 to 69 years).

Estimates also indicate that the vaccination programme has prevented around 39,100 hospitalisations in those aged 65 years and over in England (approximately 4,700 admissions in those aged 65 to 74, 15,400 in those aged 75 to 84 and 19,000 in those aged 85 and over).

UK Health and Social Care Secretary Matt Hancock said: "This new data shows the vaccine saves lives and protects you from ending up in hospital with COVID-19."

"The 13,000 deaths and the 39,100 hospitalisations that have been prevented are not just numbers. They are our family, our friends, our loved ones and a poignant reminder of the impact the vaccine is having," Hancock said.

"With the threat of new variants, it’s never been more important to get the vaccine. We have now extended the call to 34 and 35 year olds, so when you get the offer, please get the jab," he said.